Remegen Pharma (Yantai) Co., Ltd.'s stocks experienced abnormal fluctuations in trading, according to an announcement.
Reply to the Inquiry Letter regarding Unusual Fluctuation in Trading of Stocks of Remegen Biopharmaceutical (Yantai) Co., Ltd.
RemeGen Co., Ltd.: Investor Relations Activity Record Form for July 9th, 2024
Announcement of Remegen Pharmaceutical (Yantai) Co., Ltd. regarding the plan of the actual controller to increase shareholding in the company.
Announcement from Remegen regarding change of signed registered accountant
Legal opinion on the 2023 Remegen annual shareholder meeting.
Remegen's 2023 Annual Shareholders' Meeting Resolution Announcement
RemeGen Co., Ltd.: Investor Relations Activity Record June 19, 2024
Remegen's 2023 Annual Shareholders Meeting materials.
Legal opinion on the first interim shareholder meeting of Remegen in 2024.
Remegen announces the resolution of the first extraordinary shareholders meeting in 2024.
Announcement of Remegen's Private Investment Fund Settlement Account Opening
Announcement listed in Hong Kong
Remegen's first interim shareholder meeting materials for 2024.
Notice of Rongchang Biopharmaceutical (Yantai) Co., Ltd. on convening the 2024 First Extraordinary General Meeting of Shareholders
Notice of Rongchang Biopharmaceutical (Yantai) Co., Ltd. on convening the 2023 Annual General Meeting of Shareholders
Rongchang Biotech's announcement on the completion of some fund-raising special account sales
Announcement of Resolutions of the 13th Meeting of the 2nd Board of Directors of Rongchang Biotech
Rongchang Biopharmaceutical (Yantai) Co., Ltd. 2023 Environmental, Social and Governance Report
Announcement of Resolutions of the 10th Meeting of the 2nd Board of Supervisors of Rongchang Biotech
No Data